GenSight Biologics S A : Convening notice – 2023 General Meeting
CONVENING OF THE COMBINED GENERAL MEETING ON JUNE 21, 2023 GENSIGHT BIOLOGICS A French Société Anonyme ... | May 31, 2023
Source: marketscreener.com
📰 Market Authorisation Application News
Market Authorisation Application News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Market Authorisation Application. Real-time updates on events, politics, business and more.
EffRx Pharmaceuticals Signs Exclusive License Agreement With Diurnal for the Registration and Commercialization of Efmody in Switzerland
EffRx Pharmaceuticals SA, a commercial-stage company that commercializes niche and orphan medicines in Switzerland and Europe, today announced it has recently entered into an exclusive license agreement
Source: finanznachrichten.de